Key facts
as of Sep 2026- It has raised $30.0M; the latest was Early Stage VC ($20.0M) in Aug 2025.
- Notable investors include NexPhase Capital, Kryptos Research, NGC Capital, SCI Ventures, Southbridge Health Care — 6 tracked in total.
- 1 institutional filer reports fund marks on OrangeX across 1 filings.
- Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence~$16per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for OrangeX
- ·The full record, as it builds
Create free account
No card required
Recorded secondary trades
No prints on record
No secondary trades in OrangeX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest Aug 20251 SEC-registered fund reported 1 fair-value mark on OrangeX between Aug 2025 and Aug 2025. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No rounds on record
No funding rounds for OrangeX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About OrangeX
Developer of a crypto trading platform designed to offer top-level liquidity and user experience. The company offers leverage with top-level liquidity, enabling traders in the crypto market to build their portfolios with ease and convenience.
- Sector
- Financial Services
- HQ
- Ostrava, Czech Republic
- Founded
- 2021
- Website
- orangex.com/
- Ownership
- Privately Held (backing)